Novo Nordisk A S
NONOF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000353278
No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $5.36M in total; no superinvestor holds it.
Other share classesNVO
Q2 2025 vs. Q1 2025
How the institutions holding Novo Nordisk A S changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 2 | 3 | +1 |
| Shares | 12.5K | 621.9K | +609.5K (+4,888.2%) |
| Value | $849.3K | $43.2M | +$42.3M (+4,986.5%) |
New holders (1)
Institutions that held Novo Nordisk A S at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Canoe Financial LP | 609,460 | $42.3M | 0.60% |
Sold out (0)
Institutions that held Novo Nordisk A S at the end of Q1 2025 and filed for Q2 2025 without it.
None.